-
Company Profile
Ginkgo BioWorks Inc – Company Profile
Ginkgo BioWorks Inc (Ginkgo BioWorks) a subsidiary of Ginkgo Bioworks Holdings, Inc. is a biotechnology company which offers automated organism engineering, enzyme discovery and cultured fragrances. The company also offers antibiotics, specialty chemicals, cannabinoids and others. It produces ingredients through fermentation with engineered yeasts for foods, perfumes, cosmetics markets; discover new enzymes used in applications including cheesemaking, pharmaceuticals, and stonewashed jeans. Ginkgo BioWorks also uses laboratory automation synthesis, software and automation, and high performance analytical tools to produce these products....
Add to Basket -
Analyst Opinions
Future of Consumers – Sustainability, Generative AI, Health and Wellness
Access and explore the following trends and insights from our latest report ‘Future of Consumers - Sustainability, Generative AI, Health and Wellness’: Key disruptive forces in the consumer industry - exposure on the innovative themes within the consumer industry that are emerging, accelerating, and maturing. Sustainability: Textured Vegetable Proteins (TVP) - presents the area’s innovation landscape, key players, deals and social media, and real-world innovations. Health & Wellness: Recombinant Steviol Glycosides (RSG) - presents the area’s innovation landscape, key players,...
-
Company Profile
Kangmei Pharmaceutical Co Ltd – Company Profile
Kangmei Pharmaceutical Co Ltd (Kangmei) is a manufacturer and distributor of herbal medicine. The company provides herbal raw materials and preparations. Its products include Chinese herbal medicine, bottled single product and chemical drugs, among others. Kangmei provides chemical drugs such as clarithromycin dispersible tablets, doxazosin mesylate tablets, propiverine hydrochloride tablets, and paracetamol and pseudoephedrine hydrochloride tablets. The company also offers Xinkaihe warm tea, Ginkgo thirty-seven hawthorn polyphenol capsules, Propolis, McKinley card Calcium Iron zinc and selenium chewable tablets and Happiness...
Add to Basket -
Product Insights
Colon Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Colon Cancer Pipeline Drugs Market Overview Colon cancer is cancer that starts in the large intestine (colon). There is no single cause of colon cancer. Nearly all colon cancers begin as noncancerous (benign) polyps, which slowly develop into cancer. Many cases of colon cancer have no symptoms. The following symptoms may indicate colon cancer abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, or other change in bowel habits, narrow stools, and weight loss with...
-
Product Insights
Multiple Myeloma (Kahler Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Multiple Myeloma Pipeline Products Market Report Overview Multiple myeloma is a type of cancer that is caused by malignant plasma cells that proliferate in the bone marrow and produce abnormally high amounts of a special protein. The exact cause of multiple myeloma is not clear. It mainly affects older adults. Symptoms include anemia, bleeding, nerve damage, skin lesions, bone tenderness or pain, and kidney failure. Treatment includes chemotherapy, radiation, immunosuppression, and surgery. The Multiple Myeloma Drugs in Development market research...
-
Track & Monitor
Artificial Intelligence in Pharmaceuticals: DNA polymorphism detection
Our team of industry experts has meticulously researched and analyzed the latest trends, innovations and emerging technologies in the Pharmaceuticals industry’s DNA polymorphism detection segment. By leveraging our report, you will gain invaluable insights that can revolutionise your business strategies and give you a competitive edge. Note: This is an “on-demand” report and will be delivered within 2 to 4 business days (excluding weekends and holidays) of the purchase. Certain sections in the report may be removed or altered based...
-
Product Insights
Hepatitis B Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Hepatitis B virus can cause an acute illness with symptoms that last several weeks, including yellowing of the skin and eyes (jaundice), dark urine, extreme fatigue, nausea, vomiting, and abdominal pain. The Hepatitis B pipeline market research report provides comprehensive information on the therapeutics under development for Hepatitis B, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the...
-
Thematic Analysis
China Tech – Thematic Research
China Tech Report Overview China Tech's thematic research report tackles the issue of whether China—despite severe geographic, demographic, and economic constraints—will lead the world into the Fourth Industrial Revolution by 2030. It also assesses whether this will spawn a Beijing-centered global economic security zone dependent on Chinese technology and largely independent of the West. This report also looks at the foundational technologies that will need to be advanced, converged, and widely deployed over the decade to birth and nurture the...
-
Product Insights
Influenzavirus B Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Influenza Virus B Infections pipeline market research report provides comprehensive information on the therapeutics under development for Influenza Virus B Infections, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Influenza Virus...
-
Track & Monitor
Partnerships, Licensing, Investments and M&A Deals and Trends for May 2021 in Pharmaceuticals
GlobalData's “Partnerships, Licensing, Investments and M&A Deals and Trends for May 2021 in Pharmaceuticals” report is an essential source of data and trend analysis on partnerships, licensing, mergers and acquisitions (M&As) and financings in the pharmaceuticals industry. The report provides detailed information on partnership and licensing transactions, M&As, equity/debt offerings, private equity, and venture financing registered in the pharmaceuticals industry in May 2021. The report portrays detailed comparative data on the number of deals and their value in the last...